According to GuruFocus list of 52-week highs, Aviva PLC, Xcel Energy Inc., ONEOK Inc. and GlaxoSmithKline Plc have all reached their 52-week highs.
Aviva Plc (AV, Financial) Reached the 52-Week High of $17.28
Aviva Plc is engaged in the provision of financial products and services, focused on the following lines of business: long-term insurance and savings business, general insurance and health and fund management. Aviva Plc has a market cap of $25.46 billion; its shares were traded at around $17.28 with a P/E ratio of 7.90 and P/S ratio of 0.44. The dividend yield of Aviva Plc stocks is 2.86%.
Xcel Energy Inc. (XEL, Financial) Reached the 52-Week High of $31.95
The prices of Xcel Energy Inc. (XEL, Financial) shares have reached $31.95, which is 0.2% off the 52-week high of $32.00. Xcel Energy Inc. was incorporated under the laws of Minnesota in 1909. Xcel Energy Inc. has a market cap of $15.92 billion; its shares were traded at around $31.95 with a P/E ratio of 16.70 and P/S ratio of 1.45. The dividend yield of Xcel Energy Inc. stocks is 3.57%. Xcel Energy Inc. had an annual average earnings growth of 3.80% over the past 10 years.
Xcel Energy Inc. has released its fourth quarter 2013 results ended Dec. 31, 2013. Diluted EPS were $0.30, flat from a year ago.
ONEOK Inc. (OKE, Financial) Reached the 52-Week High of $62.69
ONEOK Inc., an Oklahoma corporation, was organized on May 16, 1997. ONEOK Inc. has a market cap of $13.03 billion; its shares were traded at around $62.69 with a P/E ratio of 49.30 and P/S ratio of 0.90. The dividend yield of ONEOK Inc. stocks is 2.42%. ONEOK Inc. had an annual average earnings growth of 7.90% over the past 10 years.
ONEOK Inc. reported fourth quarter 2013 net income of $228.4 million ($0.67 per share), compared with $210.4 million ($0.66 per share) in the prior year quarter. EBITDA was $350.4 million compared with $314.7 million, and distributable cash flow was $254 million.
GlaxoSmithKline Plc (GSK, Financial) Reached the 52-Week High of $55.76
GlaxoSmithKline Plc incorporated in UK. GlaxoSmithKline Plc has a market cap of $135.35 billion; its shares were traded at around $55.76 with a P/E ratio of 14.90 and P/S ratio of 3.05. The dividend yield of GlaxoSmithKline Plc stocks is 4.43%. GlaxoSmithKline Plc had an annual average earnings growth of 3.10% over the past 10 years. GuruFocus rated GlaxoSmithKline Plc the business predictability rank of 2-star.
For its fourth quarter of 2013, the company reported EPS of $0.50 and turnover of $11.58 billion.
Check out the complete list of 52-week highs.
